Ursolic acid
|
Oldenlandia diffusa
|
Lung cancer |
Mitotic kinase activity inhibition |
[71] |
Punica granatum
|
Breast cancer |
Anti-cancer property via Akt/mTOR signaling |
[72] |
Apigenin
|
Sorghum bicolor
|
Colon cancer |
Inhibiting ATP-binding cassette (ABC) transporter expression |
[73] |
Quercetin
|
Vigna unguiculat
|
Colon cancer |
Inhibiting multidrug resistance gene 1 (MDR1) expression |
[74] |
Kaempferol
|
Alangium salvifolium
|
Ascitic lymphoma |
Inhibition of dihydrofolate inhibition, thereby damaging DNA of a cancerous cell |
[75] |
Lupeol
|
Dillenia indica
|
Leukemia |
Induces PCD |
[76] |
Aurantio-obtusin
|
Cassia tora
|
Cervical cancer |
Inhibits proliferation and induces apoptosis |
[77] |
Luteolin
|
Eclipta alba
|
Glioma |
Down regulating NF-κBleads to DNA damage and ultimately apoptosis. |
[78] |
Paniculatine
|
Celastrus paniculatus
|
Breast cancer |
Growth inhibition followed by apoptosis mediated by p53 and mitogen activated protein (MAP) kinases |
[79] |
Linalool
|
Cinnamomum cassia
|
Cervical carcinoma |
Reduced expression of Her-2 oncoprotein |
[80] |
Carthamin
|
Carthamus tinctorius
|
Colon cancer |
Caspase-3, -7, and -9 upregulation and Bcl-2 downregulation |
[81] |
Resveratrol
|
Vitis vinifera
|
Colorectal cancer |
Regulation of p53 and inhibition of IGF-IR pathway |
[82] |
Fisetin
|
Fragaria ananassa
|
Hepatic cancer |
Modulated mitogen activated protein kinases (MAPK) and CDK5 signaling |
[83] |
Withaferin A
|
Withania somnifer
|
Colon cancer |
Inhibition of (signal transducer and activator of transcription 3) STAT3 pathway |
[84] |
Ferulic acid
|
Ferula asafetida
|
Mammary carcinogenesis |
Reduction in cytochrome p450 levels |
[85] |
Safranal
|
Crocus sativus
|
Cervical cancer |
Inhibition of malignant cell line proliferation and induces apoptosis |
[86] |
Limonene
|
Citrus sinensis
|
Breast cancer |
Induction of apoptosis through upregulation of pro-apoptotic factors and down-regulation of anti-apoptotic factors |
[87] |
Gingerol
|
Zingiber officinale
|
Colon cancer |
G2/M cell cycle arrest, activation of PI3K/Akt pathway, and apoptosis induction |
[88] |
Malic acid
|
Actinidia deliciosa
|
Brain tumor |
Activates pro-apoptotic genes |
[89] |
Podophyllotoxin
|
Podophyllum spp. |
Testicular and breast cancer |
Cell division blockage at metaphase of mitosis |
[90] |
Berberine
|
Berberis vulgaris
|
Colon cancer |
Cell cycle arrest and synergistic effect with drugs |
[91] |
Combretastatin
|
Combretum caffrum
|
Leukemia |
Destabilization of microtubules |
[92] |
Ingenol mebutate
|
Euphorbia peplus
|
Prostate cancer |
Suppression of P13/Akt pathway |
[93] |
Genipin
|
Gardenia jasminoides
|
Medullobalstome |
Increase in Bax level |
[94] |
Crocin
|
Crocus sativus
|
Prostate cancer |
G2/M Cell cycle arrest |
[95] |
|
Bilobetin
|
Ginkgo biloba
|
Leukemia |
Cell cycle arrest at G2/M |
[96] |
Amentoflavone
|
Selaginella tamariscina
|
Ovarian cancer |
Inducing DNA damage by interfering in microtubule dynamics |
[97] |
Brusatol
|
Brucea javanica
|
Lung cancer |
Stimulation of ROS; G0-G1 cell cycle arrest and decrease in glutathione levels |
[98] |
Brucea javanica oil
|
Brucea javanica
|
Hepatocellular carcinoma |
Upregulation of miRNA-29b and p53 expression levels |
[99] |
Octahydrocurcumin
|
Curcuma longa
|
Hepatocellular carcinoma |
Downregulation of murine double minute 2 (MDM2) expression levels |
[100] |